A detailed history of Cullen/Frost Bankers, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 10,017 shares of GILD stock, worth $882,297. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,017
Previous 11,184 10.43%
Holding current value
$882,297
Previous $819,000 16.12%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$63.15 - $72.88 $73,696 - $85,050
-1,167 Reduced 10.43%
10,017 $687,000
Q1 2024

May 10, 2024

SELL
$71.58 - $87.29 $15,819 - $19,291
-221 Reduced 1.94%
11,184 $819,000
Q4 2023

Feb 06, 2024

SELL
$73.27 - $83.09 $44,401 - $50,352
-606 Reduced 5.05%
11,405 $923,000
Q3 2023

Nov 02, 2023

SELL
$73.94 - $80.67 $29,576 - $32,268
-400 Reduced 3.22%
12,011 $900,000
Q2 2023

Aug 04, 2023

SELL
$76.01 - $86.7 $157,036 - $179,122
-2,066 Reduced 14.27%
12,411 $956,000
Q1 2023

May 05, 2023

SELL
$77.31 - $88.08 $67,182 - $76,541
-869 Reduced 5.66%
14,477 $1.2 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $21,188 - $30,419
-340 Reduced 2.17%
15,346 $1.32 Million
Q3 2022

Nov 07, 2022

SELL
$59.54 - $68.01 $39,475 - $45,090
-663 Reduced 4.06%
15,686 $968,000
Q2 2022

Aug 05, 2022

SELL
$57.72 - $65.01 $75,151 - $84,643
-1,302 Reduced 7.38%
16,349 $1.01 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $1,448 - $1,814
25 Added 0.14%
17,651 $1.05 Million
Q4 2021

Feb 07, 2022

SELL
$64.88 - $73.64 $4,866 - $5,523
-75 Reduced 0.42%
17,626 $1.28 Million
Q3 2021

Nov 04, 2021

SELL
$67.69 - $73.03 $71,683 - $77,338
-1,059 Reduced 5.64%
17,701 $1.24 Million
Q2 2021

Aug 05, 2021

BUY
$63.47 - $69.35 $28,878 - $31,554
455 Added 2.49%
18,760 $1.29 Million
Q1 2021

May 05, 2021

BUY
$60.0 - $68.46 $98,760 - $112,685
1,646 Added 9.88%
18,305 $1.18 Million
Q4 2020

Feb 08, 2021

BUY
$56.65 - $64.55 $103,272 - $117,674
1,823 Added 12.29%
16,659 $971,000
Q3 2020

Nov 05, 2020

SELL
$62.1 - $78.08 $611,622 - $769,009
-9,849 Reduced 39.9%
14,836 $937,000
Q2 2020

Aug 05, 2020

SELL
$72.34 - $84.0 $135,058 - $156,828
-1,867 Reduced 7.03%
24,685 $1.9 Million
Q1 2020

May 01, 2020

BUY
$62.63 - $80.22 $105,406 - $135,010
1,683 Added 6.77%
26,552 $1.99 Million
Q4 2019

Feb 06, 2020

SELL
$61.62 - $67.78 $53,301 - $58,629
-865 Reduced 3.36%
24,869 $1.62 Million
Q3 2019

Nov 01, 2019

BUY
$62.51 - $69.0 $40,318 - $44,505
645 Added 2.57%
25,734 $1.63 Million
Q2 2019

Aug 01, 2019

SELL
$61.87 - $69.38 $76,595 - $85,892
-1,238 Reduced 4.7%
25,089 $1.7 Million
Q1 2019

Apr 30, 2019

BUY
$62.53 - $70.05 $74,535 - $83,499
1,192 Added 4.74%
26,327 $1.7 Million
Q4 2018

Feb 06, 2019

BUY
$60.54 - $79.0 $38,987 - $50,876
644 Added 2.63%
25,135 $1.57 Million
Q3 2018

Oct 29, 2018

SELL
$71.28 - $78.92 $1.27 Million - $1.41 Million
-17,870 Reduced 42.19%
24,491 $1.89 Million
Q2 2018

Jul 27, 2018

SELL
$64.88 - $75.68 $720,038 - $839,896
-11,098 Reduced 20.76%
42,361 $3 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $247,437 - $301,653
-3,397 Reduced 5.97%
53,459 $4.03 Million
Q4 2017

Jan 31, 2018

SELL
$71.15 - $83.52 $163,929 - $192,430
-2,304 Reduced 3.89%
56,856 $4.07 Million
Q3 2017

Nov 02, 2017

BUY
$72.11 - $85.47 $4.27 Million - $5.06 Million
59,160
59,160 $4.79 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.